Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

Questionnaires were used by the investigators to assess the acceptability of the Clickhaler®, to compare it with that of the prestudy inhaler, and to assess patient technique. Four- or three ...